Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
01/2007
01/11/2007US20070010674 Method of synthesizing camptothecin-relating compounds
01/11/2007US20070010545 Solid forms of a chemokine receptor antagonist and methods of use thereof
01/11/2007US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/11/2007US20070009541 Drug conjugate composition
01/11/2007US20070009540 Drug conjugate composition
01/11/2007US20070009539 a liquid and/or lyophilized mixture of buffers and humanized antibody that binds tumor antigens, chemically coupled to a maytansine derivative, used as antitumor and/or anticarcinogenic agents
01/10/2007EP1740710A1 Labeling of rapamycin using rapamycin-specific methylases
01/10/2007EP1740579A1 Tricyclic pyrazole kinase inhibitors
01/10/2007EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
01/10/2007EP1740100A1 Xanthene dyes
01/10/2007CN1894259A Rifamycin analogs and uses thereof
01/10/2007CN1894258A Compositions useful as inhibitors of protein kinases
01/10/2007CN1894257A Process for making camptothecin derivatives
01/10/2007CN1894256A Method for preparing spironolactone compounds
01/10/2007CN1891704A Dipetidase tetrainhibitor, and its preparing method and use
01/10/2007CN1891703A Chelerythrine compound and its preparing method
01/10/2007CN1891260A Corydalis decumbens extract, and its preparing method and use
01/10/2007CN1294136C Novel ligand for nicotinic acety/choline receptors useful in therapy
01/09/2007US7160894 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine
01/09/2007US7160877 Aliphatic nitrogen-containing 5-membered ring compound
01/09/2007US7160485 Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives, related anisotropic films, and methods for making
01/09/2007CA2296731C Methods of preparing and purifying 9-nitro-20-camptothecin
01/04/2007WO2007002867A1 Abca1 elevating compounds
01/04/2007WO2007002181A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
01/04/2007WO2007001939A1 Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
01/04/2007WO2007000465A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
01/04/2007WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
01/04/2007WO2006078865B1 Direct racemization of indole derivatives
01/04/2007WO2006041872A3 Thrombin receptor antagonists
01/04/2007WO2006039325A3 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
01/04/2007US20070004768 Hydroxamates of isoquinolines, imidazopyridines and pyrrolopyridines, used to treat AIDS and AIDS-related complex
01/04/2007US20070004718 Ion channel modulating compounds and uses thereof
01/04/2007US20070004715 Novel spiro-quinuclidinyl derivatives for the treatment of central nervous system disorders
01/04/2007US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
01/04/2007US20070004702 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
01/04/2007CA2613703A1 Abca1 elevating compounds
01/03/2007EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
01/03/2007EP1737869A1 Regiospecific synthesis of rapamycin 42-ester derivatives
01/03/2007EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
01/03/2007EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides
01/03/2007EP1737458A2 R(-)-11-hydroxyaporphine derivatives and uses thereof
01/03/2007EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
01/03/2007EP1221439B1 Tetrahydroquinoline derivatives
01/03/2007EP0975619B1 INTENSE COLOURING PHOTOCHROMIC 2H-NAPHTHO[1,2-b] PYRANS AND HETEROCYCLIC PYRANS
01/03/2007CN1890248A Novel compounds
01/03/2007CN1890225A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
01/03/2007CN1889955A Tricyclic imidazopyridines for use as gastric secretion inhibitors
01/03/2007CN1293074C Arylindenopyridines with PDE inhibiting activity
01/03/2007CN1293059C New Carboxglic acid derivative, its preparation and application
01/02/2007US7157489 HIV protease inhibitors
01/02/2007US7157487 Vla-4 inhibitors
01/02/2007US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection
01/02/2007US7157447 Useful for treating HIV infection and AIDS
01/02/2007CA2315909C Novel acronycine derivatives, preparation method and pharmaceutical compositions
01/02/2007CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use
12/2006
12/28/2006WO2006138549A1 Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
12/28/2006WO2006138217A1 Aspartyl protease inhibitors
12/28/2006WO2006137527A1 Thiazole derivative
12/28/2006WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof
12/28/2006WO2006137350A1 Novel furopyridine derivative, pharmaceutical composition comprising the derivative, and use of the derivative or composition
12/28/2006WO2006136552A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
12/28/2006WO2006136309A1 Cripowellins and synthetic derivatives thereof used as medicaments
12/28/2006WO2006107273A8 Compounds having progestogenic activity and their use
12/28/2006WO2006093719A8 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one
12/28/2006WO2006082409A8 Tricyclic cytoprotective compounds
12/28/2006US20060293523 Novel rhodamine dyes
12/28/2006US20060293345 Heterobicyclic metalloprotease inhibitors
12/28/2006US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase
12/28/2006US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
12/28/2006US20060293301 Use of compounds that inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(5-fluoro-1H-indol-3-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example; depression, anxiety, premenstrual syndrome, attention deficit disorder, eating disorders
12/28/2006US20060293286 Resistant-repellent retroviral protease inhibitors
12/28/2006CA2612913A1 Cripowellins and synthetic derivatives thereof used as medicaments
12/28/2006CA2612112A1 Process for the production of intermediates for the preparation of tricyclic benzimidazoles
12/28/2006CA2612109A1 Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
12/28/2006CA2610815A1 Aspartyl protease inhibitors
12/27/2006EP1735318A2 7h-8,9-dihydro-pyrano(2,3-c)imidazo(1,2a)pyridine derivatives and their use as gastric acid secretion inhibitors
12/27/2006EP1735317A1 Annelated quinoline derivatives as pesticide
12/27/2006EP1735281A2 Synthesis of indenoisoquinoliniums and methods of use
12/27/2006EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer
12/27/2006EP1734820A2 Imidazopyrazines, imidazopyridines, and imidazopyrimidines as crf1 receptor ligands
12/27/2006EP1149118B1 Method of producing derivatized polymers
12/27/2006CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/27/2006CN1886406A Pyrano-quinolines, pyrano-quinolinones, combinations thereof, photochromic compositions and articles
12/27/2006CN1884277A Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation
12/27/2006CN1291989C Method for separating lycorine from plant extract
12/26/2006US7153960 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
12/26/2006US7153946 Molecular conjugates for use in treatment of cancer
12/26/2006US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders
12/26/2006US7153879 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders
12/26/2006US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006US7153850 Lactam compounds and pharmaceutical use thereof
12/26/2006US7153849 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder
12/26/2006US7153847 Dipeptide-substituted benzo- and dibenzocaprolactams, which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease
12/21/2006WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006WO2006134485A1 Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as orl1-receptor antagonists
12/21/2006WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006WO2006133805A1 Tetrahydroquinoline derivatives
12/21/2006US20060287530 Process For Preparing New Tiotropium Salts, New Tiotropium Salts As Such and Pharmaceutical Compositions Thereof
12/21/2006US20060287529 Solid phase synthesis of antitumoral compounds
12/21/2006US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders